TONIX PHARMACEUTICALS HOLDING CORP. Basic Shares Outstanding (Weighted Average)
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Basic Shares Outstanding (Weighted Average) of 16.64 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 16.64M shares, a 127.03% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 13.71M shares, a 131.26% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.84M shares, a 425.82% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 8.92M shares, a 1323.84% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for fiscal 2025 was 8.51M shares, a 1055.90% increase from fiscal 2024.
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for fiscal 2024 was 736.34K shares, a 9191.34% increase from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for fiscal 2023 was 7.92K shares, a 99.86% decline from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. weighted average number of shares outstanding, basic for fiscal 2022 was 5.84M shares, a 48.70% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 16.64M shares 10-Q · filed 2026-08-10 | 15.18M shares 10-Q · filed 2026-08-10 | 14.06M shares derived: average of 3 quarters · filed 2026-08-10 | 12.78M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | 13.71M shares 10-Q · filed 2026-05-11 | 12.77M shares derived: average of 2 quarters · filed 2026-05-11 | 11.49M shares derived: average of 3 quarters · filed 2026-05-11 | 10.45M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | 11.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 10.38M shares derived: average of 2 quarters · filed 2026-03-12 | 9.36M shares derived: average of 3 quarters · filed 2026-08-10 | 8.51M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 8.92M shares 10-Q · filed 2025-11-10 | 8.13M shares derived: average of 2 quarters · filed 2026-08-10 | 7.40M shares 10-Q · filed 2025-11-10 | 6.11M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | 7.33M shares 10-Q · filed 2026-08-10 | 6.63M shares 10-Q · filed 2026-08-10 | 5.17M shares derived: average of 3 quarters · filed 2026-08-10 | 4.03M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | 5.93M shares 10-Q · filed 2026-05-11 | 4.09M shares derived: average of 2 quarters · filed 2026-05-11 | 2.93M shares derived: average of 3 quarters · filed 2026-05-11 | 2.21M shares derived: average of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | 2.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.44M shares derived: average of 2 quarters · filed 2026-03-12 | 972.82K shares derived: average of 3 quarters · filed 2026-03-12 | 736.34K shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 626.67K shares 10-Q · filed 2025-11-10 | 62.12M shares 10-Q · filed 2024-11-12 | 333.84K shares derived: average of 2 quarters · filed 2025-11-10 | 231.52K shares 10-Q · filed 2025-11-10 | 23.14M shares 10-Q · filed 2024-11-12 | -285.20K shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | 41.01K shares 10-Q · filed 2025-08-11 | 4.09M shares 10-Q · filed 2024-08-16 | 34.45K shares 10-Q · filed 2025-08-11 | 3.43M shares 10-Q · filed 2024-08-16 | -589.15K shares derived: average of 3 quarters · filed 2025-08-11 | -260.82K shares derived: average of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | 27.89K shares 10-Q · filed 2025-05-12 | 80.88M shares 10-Q · filed 2024-05-13 | -904.23K shares derived: average of 2 quarters · filed 2025-05-12 | -361.43K shares derived: average of 3 quarters · filed 2025-05-12 | -127.06K shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -1.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -556.08K shares derived: average of 2 quarters · filed 2025-03-18 | -178.71K shares derived: average of 3 quarters · filed 2025-03-18 | 7.92K shares 10-K · filed 2025-03-18 | 17.04M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 724.19K shares 10-Q · filed 2024-11-12 | 15.33M shares 10-Q · filed 2023-11-09 | 650.12K shares derived: average of 2 quarters · filed 2024-11-12 | 622.68K shares 10-Q · filed 2024-11-12 | 12.08M shares 10-Q · filed 2023-11-09 | 5.39M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 576.05K shares 10-Q · filed 2024-08-16 | 10.59M shares 10-Q · filed 2023-08-10 | 571.09K shares 10-Q · filed 2024-08-16 | 10.43M shares 10-Q · filed 2023-08-10 | 6.95M shares derived: average of 3 quarters · filed 2024-08-16 | 6.92M shares derived: average of 4 quarters · filed 2024-08-16 | ||
| 2023-03-31 | 10.27M shares 10-Q · filed 2024-05-13 | 63.35M shares 10-Q · filed 2023-05-08 | 10.13M shares derived: average of 2 quarters · filed 2024-05-13 | 9.04M shares derived: average of 3 quarters · filed 2024-05-13 | 7.67M shares derived: average of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | 10.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 8.42M shares derived: average of 2 quarters · filed 2024-04-01 | 6.81M shares derived: average of 3 quarters · filed 2024-04-01 | 5.84M shares 10-K · filed 2024-04-01 | 35.74M shares 10-K · filed 2023-03-13 | |||
| 2022-09-30 | 6.84M shares 10-Q · filed 2023-11-09 | 41.94M shares 10-Q · filed 2022-11-07 | 5.21M shares derived: average of 2 quarters · filed 2023-11-09 | 4.46M shares 10-Q · filed 2023-11-09 | 27.07M shares 10-Q · filed 2022-11-07 | 10.28M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 3.58M shares 10-Q · filed 2023-08-10 | 22.40M shares 10-Q · filed 2022-08-08 | 3.11M shares 10-Q · filed 2023-08-10 | 19.46M shares 10-Q · filed 2022-08-08 | 11.43M shares derived: average of 3 quarters · filed 2023-08-10 | 11.47M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 16.45M shares 10-Q · filed 2023-05-08 | 522.06M shares 10-Q · filed 2022-05-09 | 15.35M shares derived: average of 2 quarters · filed 2023-05-08 | 14.10M shares derived: average of 3 quarters · filed 2023-05-08 | 13.19M shares derived: average of 4 quarters · filed 2023-05-08 | |||
| 2021-12-31 | 14.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 12.92M shares derived: average of 2 quarters · filed 2023-03-13 | 12.11M shares derived: average of 3 quarters · filed 2023-03-13 | 11.39M shares 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | 11.58M shares 10-Q · filed 2022-11-07 | 11.03M shares derived: average of 2 quarters · filed 2022-11-07 | 10.43M shares 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | 10.48M shares 10-Q · filed 2022-08-08 | 9.84M shares 10-Q · filed 2022-08-08 | ||||||
| 2021-03-31 | 290.11M shares 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |